You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients

 

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

AbstractFullPdf
Jun 2021494496212
Jul 202164764758
Aug 202158959050
Sep 202114514524
Oct 202112912935
Nov 202111811947
Dec 202112112136
Jan 2022919527
Feb 2022808031
Mar 2022969737
Apr 2022969841
May 202211611732
Jun 202212212432
Jul 2022899334
Aug 2022545619
Sep 2022656932
Oct 2022737441
Nov 2022747418
Dec 2022535320
Jan 2023383817
Feb 2023646529
Mar 2023262830
Apr 202325259
May 2023262617
Jun 2023414119
Jul 2023393916
Aug 2023373720
Sep 2023414117
Oct 2023414529
Nov 2023353617
Dec 2023474725
Jan 2024373821
Feb 2024383922
Mar 2024545474
Total384138761188